Dicarbonyl-modified low-density lipoproteins are key inducers of LOX-1 and NOX1 gene expression in cultured human umbilical vein endotheliocytes
Year: 2023
Type: article
Abstract: The expression of LOX-1 and NOX1 genes in human umbilical vein endotheliocytes (HUVECs) when cultured in the presence of low-density lipoproteins (LDL) modified with various natural dicarbonyls was investigated for the first time. It was found that of the investigated dicarbonyl-modified LDLs (malondialdehyde (MDA)-modified LDLs, glyoxal-modified LDLs, and methylglyoxal-modified LDLs), namely MDA-modified LDLs caused the greatest induction of LOX-1 and NOX1 genes, as well as genes of antioxidant enzymes and genes of signaling molecules in HUVECs. MDA-modified LDLs also induce the highest peroxiredoxins expression of the studied antioxidant enzyme genes. The key role of dicarbonyl-modified LDLs in the molecular mechanisms of vascular wall damage and endothelial dysfunction is discussed.
Source: Biochemistry (Moscow)
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4394749685
